ACT - POC clinical study
Research payments
$253,928
Through program year 2023, $253,928 in research payments was reported against ACT - POC clinical study, across 21 payments, paid by Sanofi US Services Inc..
- Paid by
- Sanofi US Services Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $206,365 | 16 |
| 2022 | Research | $47,563 | 5 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Lucky Flores Hialeah, FL Named on 4 payments
- Christopher Ferris Charlotte, NC Named on 2 payments
- Radha Tamerisa Katy, TX Named on 1 payment
- Dharmendra Verma Katy, TX Named on 1 payment
- Alan Weintraub Tampa, FL Named on 1 payment
- Rudrajit Rai Columbia, MD Named on 1 payment
- Timothy Ritter Southlake, TX Named on 1 payment
- Curtis Freedland New Port Richey, FL Named on 1 payment
- George Duvall Tyler, TX Named on 1 payment
- Karen Simon Oxnard, CA Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.